Role of Membrane Lipids in the Regulation of Erythrocytic Oxygen-Transport Function in Cardiovascular Diseases

Table 2

Distribution of erythrocytes sizes in the course of SA patients’ treatment and healthy persons (means ± SD).

Patients groups	Indicators
	Phase image area of erythrocyte, , µm^2	Erythrocyte volume, , µm^3	The mean value of optical path difference (OPD), ,
Donors	110.92 ± 0.54	89.43 ± 3.63	60.92 ± 2.36
SA patients before treatment	87.35 ± 3.01	126.29 ± 3.15	108.44 ± 2.28
SA+HT patients before treatment	92.32 ± 4.77	109.21 ± 3.61	88.72 ± 4.30
SA patients after treatment	99.44 ± 2.45	118.47 ± 2.68	89.35 ± 1.92
SA+HT patients after treatment	101.30 ± 1.95	108.88 ± 2.04	80.61 ± 1.51

Reliability in relation to donors’ indicators.
Reliability in relation to pretreatment indicators at .